Can Aphria Inc. (TSX:APH) Live Up to its True Potential?

Skilled management is Aphria Inc.’s (TSX:APH) key strength.

think, plan, and act to work towards your financial goals

Canadian marijuana stocks are bracing for an exciting year. It’s the first time producers can start selling recreational marijuana directly to consumers. In anticipation, the largest producers have all issued equity, raised capital, and invested in production facilities to boost capacity.

One of the top three players is Leamington, Ontario-based Aphria (TSX:APH). The company seems well positioned to carve out a chunk of the growing market for medical and recreational cannabis, not just in Canada but across the world.

Aphria already has access to over 12 countries. This includes a subsidiary in Australia that covers the pan-Asian market, operations in Lesotho that offer access to the African continent, and assets in Latin America. The two most interesting markets from Aphria’s roster are Germany and the United States.

CEO Vic Neufeld has mentioned his ambitions to position the company as a dominant player in Germany, where he expects the medical marijuana market to be multiple times larger than the domestic market in Canada. Meanwhile, the United States is, and is likely to remain, the largest consumer of both medical and recreational cannabis in the world.

The Aphria team has spent much of the past few years consolidating its position in Canada. With annual production expected to reach 255,000 kgs by the end of 2019 and a sales agreement with Great North Distributors that offers access to over 99% of Canada’s consumer market, Aphria is clearly competing against the likes of Aurora Cannabis and Canopy Growth Corp a position of strength.

There’s no doubt the competition for this market is going to intensify, as the market price stabilizes, supply chains mature, and the regulatory frameworks in different parts of the world are fine-tuned. To survive the next few turbulent years, producers need a strong balance sheet, a durable supply network, and some sort of competitive edge.

Aphria seems to tick all the boxes. It’s holding on to over $350 million in what the company calls “deployable assets.” These assets include cash, cash equivalents, and marketable securities, but the bulk (nearly $319 million) comes from the recent bought deal financing. In other words, Aphria sold stock just as the market was inflating to historic highs. Meanwhile, the company’s debt-to-equity ratio is barely 0.058 times.

Management’s decisions to raise capital at the right time and keep debt negligible is a smart move and augurs well for future growth. Aphria now has access to all the important markets and continues to invest in boosting production through its Aphria One project.

At the same time, the company understands the range of products that can use marijuana as an enhancing ingredient. It already offers edibles, concentrates, vapes, and softgel capsules that were developed in-house. Going forward, research partnerships with over 10 Canadian universities should enhance the company’s intellectual property.

In my opinion, Aphria’s strong fundamentals and unique partnerships reflect something more than just a competitive advantage. It shows management’s ability to navigate this market with finesse. This pragmatic leadership style should help the company live up to its own ambitions and true potential.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no positions in the companies mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »